Published in Kidney Int on July 01, 1994
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A (2003) 2.79
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest (1997) 1.96
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest (2006) 1.57
Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev (2005) 1.51
Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol (2006) 1.47
Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury. Kidney Int (2014) 1.44
Overview of complement activation and regulation. Semin Nephrol (2013) 1.26
Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest (1995) 1.10
Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol (1997) 1.10
Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC). Clin Exp Immunol (2006) 1.06
Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J Virol (2008) 1.05
Tissue distribution of the rat analogue of decay-accelerating factor. Immunology (1999) 1.01
Complement in glomerular injury. Semin Immunopathol (2007) 0.99
The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. J Immunol (2010) 0.95
Allograft rejection: effect of local synthesis of complement. Springer Semin Immunopathol (2005) 0.85
Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin Exp Immunol (2002) 0.83
The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83
Role of complement in multiorgan failure. Clin Dev Immunol (2012) 0.83
An update on the pathomechanisms and future therapies of Alport syndrome. Pediatr Nephrol (2012) 0.82
Tissue distribution of the guinea-pig decay-accelerating factor. Immunology (1998) 0.81
Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest (2010) 0.80
Complement regulation in renal disease models. Semin Nephrol (2013) 0.80
Distribution of membrane cofactor protein (MCP/CD46) on pig tissues. Relevance To xenotransplantation. Immunology (1999) 0.77
Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis. PLoS One (2014) 0.77
Complement activation in progressive renal disease. World J Nephrol (2015) 0.77
A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H. J Am Soc Nephrol (2015) 0.76
Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury. Kidney Int (2016) 0.76
C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria. World J Nephrol (2016) 0.75
Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep. Acta Vet Scand (2015) 0.75
The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol (2000) 7.48
Identification and characterization of a fibroblast marker: FSP1. J Cell Biol (1995) 6.33
Identification of the coding sequence for a reverse transcriptase-like enzyme in a transposable genetic element in Drosophila melanogaster. Nature (1985) 4.31
Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum (1980) 3.77
An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med (1999) 3.76
The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat Med (1995) 2.79
Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell (1997) 2.77
Oxidative degradation of squalene by Arthrobacter species. Appl Microbiol (1975) 2.73
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (1998) 2.62
Neurotransmitter functions of mammalian tachykinins. Physiol Rev (1993) 2.59
Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy (2006) 2.48
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol (1994) 2.36
Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives. Chem Pharm Bull (Tokyo) (2000) 2.30
Evolutionary adaptation of plasmid-encoded enzymes for degrading nylon oligomers. Nature (1984) 2.29
The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J (1996) 2.22
CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med (1992) 2.13
Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature (1996) 2.13
Diagnosis and management of heterotopic pancreas. Int Surg (1993) 2.04
Detection of rotavirus in faeces by latex agglutination. J Immunol Methods (1981) 2.01
The structure of inducing factors for virginiamycin production in Streptomyces virginiae. J Antibiot (Tokyo) (1987) 1.99
Structure of a beta-galactosidase gene of Bacillus stearothermophilus. J Bacteriol (1986) 1.99
Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969. Cancer (1973) 1.99
A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol (1989) 1.98
Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther (2001) 1.95
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry (2001) 1.94
6-Aminohexanoic acid cyclic dimer hydrolase. A new cyclic amide hydrolase produced by Achromobacter guttatus KI74. Eur J Biochem (1977) 1.91
JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol (1999) 1.90
Genes affecting the productivity of alpha-amylase in Bacillus subtilis Marburg. J Bacteriol (1975) 1.88
Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr (1991) 1.83
Purification and characterization of 6-aminohexanoic-acid-oligomer hydrolase of Flavobacterium sp. Ki72. Eur J Biochem (1981) 1.82
Oxidation of linear terpenes and squalene variants by Arthrobacter sp. Appl Environ Microbiol (1977) 1.79
Control of cell division by sex factor F in Escherichia coli. I. The 42.84-43.6 F segment couples cell division of the host bacteria with replication of plasmid DNA. J Mol Biol (1984) 1.73
Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement. J Immunol (1989) 1.70
Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int (2002) 1.69
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol (1994) 1.68
Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer (1998) 1.65
Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells (2001) 1.65
Prospective randomized trial to compare the stapled double lumen pouch and the sutured quadruple pouch for restorative proctocolectomy. Br J Surg (1988) 1.64
Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl Acad Sci U S A (1997) 1.62
Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology (1993) 1.60
Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry (1984) 1.60
Mapping quantitative trait loci for proteinuria-induced renal collagen deposition. Kidney Int (2008) 1.58
Crystal nephropathy: a variant form of myeloma kidney--a case report and review of the literature. Clin Nephrol (2001) 1.58
Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer (1998) 1.57
Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C. J Gastroenterol Hepatol (1997) 1.57
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency. J Med Chem (1990) 1.56
Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci U S A (1997) 1.56
Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation (2001) 1.56
Plasmid control of 6-aminohexanoic acid cyclic dimer degradation enzymes of Flavobacterium sp. KI72. J Bacteriol (1980) 1.55
FAT is a component of glomerular slit diaphragms. Kidney Int (2001) 1.53
Cavitary lung cancer with an aspergilloma-like shadow. Lung Cancer (1999) 1.53
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol (2011) 1.52
Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest (1997) 1.52
Plasmid-determined enzymatic degradation of nylon oligomers. J Bacteriol (1983) 1.50
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int (2008) 1.48
TT virus infection in hemodialysis patients. Am J Gastroenterol (1999) 1.47
Molecular cloning of the genes for xylan degradation of Bacillus pumilus and their expression in Escherichia coli. Mol Gen Genet (1983) 1.45
Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol (1998) 1.45
Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome. Hepatology (1996) 1.44
Long term results of anorectal myectomy for chronic constipation. Br J Surg (1989) 1.44
Resistance to turnip crinkle virus in Arabidopsis is regulated by two host genes and is salicylic acid dependent but NPR1, ethylene, and jasmonate independent. Plant Cell (2000) 1.42
Glomerular-basement-membrane antibody and extracorporeal shock wave lithotripsy. Lancet (1993) 1.42
In vivo effects of hyperglycemia on the outcome of acute mesangial injury in rats. J Lab Clin Med (1995) 1.41
Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol (2001) 1.40
Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy. J Hypertens (2000) 1.40
Human pregnancy serum suppresses the proliferative response of lymphocytes to autologous PHA-activated T lymphoblasts. Am J Reprod Immunol (1996) 1.40
Round fingerpad sign: an early sign of scleroderma. J Am Acad Dermatol (1991) 1.39
A case of tachycardia-induced cardiomyopathy due to chronic ectopic atrial tachycardia. Clin Cardiol (1993) 1.39
Acquired von Willebrand disease after Epstein-Barr virus infection. J Pediatr (1991) 1.39
The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem (1998) 1.39
Plants synthesize ethanolamine by direct decarboxylation of serine using a pyridoxal phosphate enzyme. J Biol Chem (2001) 1.38
Observation of an antimatter hypernucleus. Science (2010) 1.38
Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest (2000) 1.37
Isolation of two beta-xylosidase genes of Bacillus pumilus and comparison of their gene products. Eur J Biochem (1984) 1.37
Early-phase enhanced inflammatory reaction after spinal instrumentation surgery. Spine (Phila Pa 1976) (2001) 1.37
Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology (1990) 1.37
Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (1999) 1.35
Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene (1999) 1.35
Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis. Infect Immun (1983) 1.34
Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem (1993) 1.34
Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest (1986) 1.33
Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane. Nature (1974) 1.33
Crystallization and preliminary X-ray studies of Bacillus pumilus IPO xylanase. J Mol Biol (1987) 1.33
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma (1989) 1.32
Angioma serpiginosum: a report of 2 cases identified using epiluminescence microscopy. Arch Dermatol (1999) 1.31
Structure of the horseradish peroxidase isozyme C genes. Eur J Biochem (1988) 1.31
Ia afferent excitation of motoneurones in the in vitro new-born rat spinal cord is selectively antagonized by kynurenate. J Physiol (1986) 1.31
High homology between 6-aminohexanoate-cyclic-dimer hydrolases of Flavobacterium and Pseudomonas strains. J Bacteriol (1989) 1.29
Tissue distribution of complement regulatory membrane proteins in rats. Immunology (1994) 1.29
Purification of 1F5 antigen that prevents complement attack on homologous cell membranes. J Immunol (1990) 1.28
Femtosecond laser-assisted three-dimensional microfabrication in silica. Opt Lett (2001) 1.28
Microbial Transformation of Squalene: Terminal Methyl Group Oxidation by Corynebacterium sp. Appl Environ Microbiol (1983) 1.27
A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J Biol Chem (1997) 1.26
Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am J Pathol (1985) 1.26
Restriction of alternative complement pathway activation by sialosylglycolipids. Nature (1982) 1.26